Symptomatic despite Multiple Drug Therapy: Where do you Turn Next?
Clinicians may be reluctant to implement evidence-based guideline recommendations because they believe that patients with chronic heart failure (CHF) who are enrolled into clinical trials are not truly representative of those seen in routine practice. Moreover, there may also be perceived safety iss...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2005-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/14703203050060020501 |
_version_ | 1797285432885510144 |
---|---|
author | Aldo Pietro Maggioni |
author_facet | Aldo Pietro Maggioni |
author_sort | Aldo Pietro Maggioni |
collection | DOAJ |
description | Clinicians may be reluctant to implement evidence-based guideline recommendations because they believe that patients with chronic heart failure (CHF) who are enrolled into clinical trials are not truly representative of those seen in routine practice. Moreover, there may also be perceived safety issues associated with polypharmacy in patients with CHF. Clinicians should strive to implement guideline recommendations for the management of CHF to ensure optimal patient outcome in routine clinical practice. This case report demonstrates that symptom control may require a large number of pharmacological treatments, to be administered in accordance with guidelines. |
first_indexed | 2024-03-07T18:03:06Z |
format | Article |
id | doaj.art-eb25973992d24755bdf3bb5fda121e07 |
institution | Directory Open Access Journal |
issn | 1470-3203 1752-8976 |
language | English |
last_indexed | 2024-03-07T18:03:06Z |
publishDate | 2005-06-01 |
publisher | SAGE Publications |
record_format | Article |
series | Journal of the Renin-Angiotensin-Aldosterone System |
spelling | doaj.art-eb25973992d24755bdf3bb5fda121e072024-03-02T10:24:28ZengSAGE PublicationsJournal of the Renin-Angiotensin-Aldosterone System1470-32031752-89762005-06-01610.1177/1470320305006002050110.1177_14703203050060020501Symptomatic despite Multiple Drug Therapy: Where do you Turn Next?Aldo Pietro MaggioniClinicians may be reluctant to implement evidence-based guideline recommendations because they believe that patients with chronic heart failure (CHF) who are enrolled into clinical trials are not truly representative of those seen in routine practice. Moreover, there may also be perceived safety issues associated with polypharmacy in patients with CHF. Clinicians should strive to implement guideline recommendations for the management of CHF to ensure optimal patient outcome in routine clinical practice. This case report demonstrates that symptom control may require a large number of pharmacological treatments, to be administered in accordance with guidelines.https://doi.org/10.1177/14703203050060020501 |
spellingShingle | Aldo Pietro Maggioni Symptomatic despite Multiple Drug Therapy: Where do you Turn Next? Journal of the Renin-Angiotensin-Aldosterone System |
title | Symptomatic despite Multiple Drug Therapy: Where do you Turn Next? |
title_full | Symptomatic despite Multiple Drug Therapy: Where do you Turn Next? |
title_fullStr | Symptomatic despite Multiple Drug Therapy: Where do you Turn Next? |
title_full_unstemmed | Symptomatic despite Multiple Drug Therapy: Where do you Turn Next? |
title_short | Symptomatic despite Multiple Drug Therapy: Where do you Turn Next? |
title_sort | symptomatic despite multiple drug therapy where do you turn next |
url | https://doi.org/10.1177/14703203050060020501 |
work_keys_str_mv | AT aldopietromaggioni symptomaticdespitemultipledrugtherapywheredoyouturnnext |